NCT04916002 2025-12-05A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic CancerRegeneron PharmaceuticalsPhase 2 Terminated77 enrolled 18 charts
NCT05864144 2025-08-15A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsSensei Biotherapeutics, Inc.Phase 1/2 Active not recruiting98 enrolled
NCT06090266 2025-01-07A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer AgentsOncoResponse, Inc.Phase 1/2 Recruiting168 enrolled
NCT05094804 2023-11-02A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer AgentsOncoResponse, Inc.Phase 1/2 Unknown172 enrolled